Selective transvascular delivery of oligodeoxynucleotides to experimental brain tumors

Journal of Neuro-Oncology

Volumn 43, Issue 2, 1999, Pages 143-151

  Koga, Hiromichi ^a   Inamura, Takanori ^a   Ikezaki, Kiyonobu ^a   Samoto, Ken ^a   Matsukado, Koichiro ^a   Fukui, Masashi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Antisense; Bradykinin; Brain neoplasm; Drug delivery system; Oligodeoxynucleotides; Permeability

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; BRADYKININ; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN TUMOR; CONTROLLED STUDY; GENE THERAPY; HYBRIDIZATION; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY; LIVER; NONHUMAN; PLASMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT;

ANIMALS; BASE SEQUENCE; BETA-GALACTOSIDASE; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN NEOPLASMS; CAROTID ARTERIES; GENE THERAPY; GLIOMA; INFUSIONS, INTRA-ARTERIAL; KIDNEY; LIVER; MALE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDE PROBES; RATS; RATS, WISTAR; THIONUCLEOTIDES; TISSUE DISTRIBUTION;

EID: 0032827395     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006210901856     Document Type: Article

References (37)

1. Akhtar S, Kole R, Juliano RL: Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci 49: 1793-1801, 1991
2. Beltinger C, Saragovi HU, Smith RM, LeSauteur L, Shah N, DeDionisio L, Christensen L, Raible A, Jarett L, Gewirtz AM: Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 95: 1814-1823, 1995
3. Black KL, Cloughesy T, Huang SC, Gobin YP, Zhou Y, Grous J, Nelson G, Farahani K, Hoh CK, Phelps M: Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 86: 603-609, 1997
4. Black KL, King WA, Ikezaki K: Selective opening of the blood-tumour barrier by intracarotid infusion of leukotriene C4. Acta Neurochirur Suppl (Wien) 51: 140-141, 1990
5. Calabretta B, Skorski T, Szczylik C, Zon G: Prospects for gene-directed therapy with antisense oligodeoxynucleotides. Cancer Treat Rev 19: 169-179, 1993
6. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552, 1992
7. Eck SL, Alavi JB, Alavi A, Davis A, Hackney D, Judy K, Mollman J, Phillips PC, Wheeldon EB, Wilson JM: Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. Hum Gene Ther 7: 1465-1482, 1996
8. Elliott PJ, Hayward NJ, Huff MR, Nagle TL, Black KL, Bartus RT: Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy. Exp Neurol 141: 214-224, 1996
9. Fenstermacher JD, Cowles AL: Theoretic limitations of intracarotid infusion in brain tumor chemotherapy. Cancer Treat Rep 61: 519-526, 1977
10. Gao WY, Storm C, Egan W, Cheng YC: Cellular pharmacology of phosphorothioate homooligodeoxynucleotides in human cells. Mol Pharmacol 43: 45-50, 1993
11. Gewirtz AM, Stein CA, Glazer PM: Facilitating oligonucleotide delivery: helping antisense deliver on its promise. Proc Natl Acad Sci USA 93: 3161-3163, 1996
12. Goodarzi G, Watabe M, Watabe K: Organ distribution and stability of phosphorothioated oligodeoxyribonucleotides in mice. Biopharm Drug Dispos 13: 221-227, 1992
13. Groothuis DR, Fischer JR, Lapin G, Bigner DD, Vick NA: Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol 41: 164-185, 1982
14. Hall WA, Flores EP, Low WC: Antisense oligonucleotides for central nervous system tumors. Neurosurgery 38: 376-383, 1996
15. Ikezaki K, Inamura T, Samoto K, Matsukado K, Shono T, Koga H, Yokoyama N, Black KL, Kuwano M, Fukui M: Specificity of brain tumor capillaries and novel drug delivery system. Ann Cancer Res Ther 6: 39-40, 1997
16. Inamura T, Black KL: Bradykinin selectively opens blood-tumor barrier in experimental brain tumors. J Cereb Blood Flow Metab 14: 862-870, 1994
17. Inamura T, Nomura T, Bartus RT, Black KL: Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J Neurosurg 81: 752-758, 1994
18. Izquierdo M, Martin V, de Felipe P, Izquierdo JM, Perez-Higueras A, Cortes ML, Paz JF, Isla A, Blazquez MG: Human malignant brain tumor response to herpes simplex thymidine kinase (HSVtk)/ganciclovir gene therapy. Gene Ther 3: 491-495, 1996
19. Kalnins A, Otto K, Ruther U, Muller-Hill B: Sequence of the lacZ gene of Escherichia coli. EMBO J 2: 593-597, 1983
20. Koga H, Inamura T, Ikezaki K, Nomura T, Samoto K, Fukui M: Increased delivery of a new cisplatin analogue (254-S) in a rat brain tumor by an intracarotid infusion of bradykinin. Neurol Res 18: 244-247, 1996
21. Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S: Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Hum Gene Ther 6: 1231-1255, 1995
22. Martuza R, Malick A, Markert J, Ruffner K, Coen D: Experimental therapy of malignant glioma by means of a genetically engineered virus mutant. Science 252: 854-856, 1991
23. Matsukado K, Inamura T, Nakano S, Fukui M, Bartus RT, Black KL: Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7. Neurosurgery 39: 125-133, 1996
24. Mineta T, Rabkin S, Martuza R: Treatment of malignant gliomas using ganciclovir-hypersensitive, ribonucleotide reductase-deficient herpes simples viral mutant. Cancer Res 54: 3963-3966, 1994
25. Nakano S, Matsukado K, Black KL: Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Res 56: 4027-4031, 1996
26. Nazzaro JM, Neuwelt EA: The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73: 331-344, 1990
27. Neuwelt EA, Barnett PA, Bigner DD, Frenkel EP: Effects of adrenal cortical steroids and osmotic blood-brain barrier opening on methotrexate delivery to gliomas in the rodent: the factor of the blood-brain barrier. Proc Natl Acad Sci USA 79: 4420-4423, 1982
28. Neuwelt EA, Hill SA, Frenkel EP: Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening. Neurosurgery 15: 362-366, 1984
29. Neuwelt EA, Rapoport SI: Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors. Fed Proc 43: 214-219, 1984
30. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4: 39-69, 1993
31. Rainov NG, Zimmer C, Chase M, Kramm CM, Chiocca EA, Weissleder R, Breakefield XO: Selective uptake of viral and monocrystalline particles delivered intra-arterially to experimental brain neoplasms. Hum Gene Ther 6: 1543-1552, 1995
32. Saijo Y, Perlaky L, Wang H, Busch H: Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice. Oncol Res 6: 243-249, 1994
33. Temsamani J, Kubert M, Agrawal S: A rapid method for quantitation of oligodeoxynucleotide phosphorothioates in biological fluids and tissues. Anal Biochem 215: 54-58, 1993
34. Trojan J, Blossey B, Johnson T, Rudin S, Tykocinski M, Ilan J, Ilan J: Loss of tumorigenecity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I. Proc Natl Acad Sci USA 89: 4874-4878, 1992
35. Trojan J, Johnson T, Rudin S, Ilan J, Tykocinski M, Ilan J: Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA. Science 259: 94-97, 1993
36. Walker MD, Alexander E, Jr, Hunt WE, MacCarty CS, Mahaley M, Jr, Mealey J, Jr, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333-343, 1978
37. Walker MD, Green SB, Byar DP, Alexander E, Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley M, Jr, Mealey J, Jr, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith K, Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980